1. Whalen J. Hurdles multiply for latest drugs. Wall Street J 1 August 2011.
2. Deloitte Consulting, 2018 report, “Unlocking R&D Productivity: Measuring the return from pharmaceutical innovation 2018,” available at
www2.deloitte.com
. Last accessed 6 Jan 2019.
3. U.S. Centers for Medicare & Medicaid (CMS) report, National Health Expenditures 2017 (Highlights), available at
www.cms.gov
. Last accessed 6 Jan 2019.
4. Milne, C.-P. Is there a business in medical countermeasures for bioterror and pandemics? (White Paper, 2010). Tufts Center for the Study of Drug Development (Tufts CSDD); Boston, MA, USA.
5. Alex Murtha, Homeland Prep News, Friday, September 1, 2017.
http://webcache.googleusercontent.com/search?q=cache:YtWOf3fpbkgJ
,
https://homelandprepnews.com/stories/24000-battelles-coleman-small-companies-key-new-cbrn-medical-countermeasures/&hl=en&gl=us&strip=1&vwsrc=0
. Last accessed 26 Nov 2018.